Nicholas Arpaia and Tal Danino Win Young Innovators Award for Lung Cancer Research
Drs. Nicholas Arpaia and Tal Danino, both faculty members of Columbia University's Herbert Irving Comprehensive Cancer Center (HICCC), are recipients of the Bonnie J. Addario Lung Cancer Foundation (ALCF) and the Van Auken Private Foundation (VAPF) Young Innovators Team Award. The ALCF-VAPF recently awarded $500,000 to two teams of innovative researchers. Drs. Arpaia and Danino won for their proposal to engineer probiotics for precision lung cancer immunotherapy and to develop a novel bacteria-based cancer therapy. Combining their expertise in lung cancer immunology and synthetic biology, the investigators will design probiotic bacterial strains that find and attack lung cancer. Dr. Arpaia is currently an assistant professor in the Department of Microbiology and Immunology at Columbia University Irving Medical Center and Dr. Danino is assistant professor of biomedical engineering at Columbia Engineering.
For the full announcement, visit Bonnie J. Addario Lung Cancer Foundation, which is recognized as one of the largest international philanthropies devoted to eradicating lung cancer through research, early detection, education and treatment.